Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

UK regulator recommends changes to infant formula market

(Sharecast News) - The UK regulator has proposed a series of reforms to the infant formula market, including using plain packaging in hospitals and strengthening advertising rules, it was announced on Friday. Following a year-long investigation into the market, after accusations of high prices and limited choice, the Competition and Markets Authority found a combination of factors was leading to "poor outcomes" for parents.

In particular, it said families could save around £300 a year by switching to a cheaper brand without losing any nutritional benefits.

Sarah Cardell, chief executive of the CMA, said: "Many [parents] pick a brand at a vulnerable moment, based on incomplete information, often believing that higher prices must mean better quality. This is despite NHS advice stating that all brands will meet your baby's nutritional needs, regardless of brand or price.

"Our proposals are designed to help parents make the best choices for them and their babies.

"Our proposals will also make it easier for regulations to be property enforced, while ensuring manufacturers and retailers can be more confident in what they can and can't do according to law."

One of its core recommendations is removing brand influence in healthcare settings.

Formula manufactures - including Aptamil-owner Danone and Nestle, owner of SMA - are already heavily restricted in the UK when it comes to the advertising and promotion of baby milk, as part of wider attempts to encourage breastfeeding.

They therefore place "significant emphasis" on building brand awareness to secure customers instead, the CMA found.

The CMA has therefore recommended that when formula is given in healthcare settings, labelling should be standardised, either though non-branded containers or a white label formula specifically for the NHS.

It also recommended strengthening labelling and advertising rules.

"Claims that are intangible, or cannot easily be checked by parents, should be banned," the CMA said. "Like infant formula, advertising - including price promotions and deals - for follow-on milks should be banned."

Companies are currently banned from advertising baby formula as an alternative to breastfeeding, but are allowed to promote so-called "follow-on" products from six months.

The CMA opted against putting a price cap on formula, however, as it warned it could push up the prices of cheaper formulas as well as disincentivising breastfeeding.

But it said parents should be allowed to use vouchers, loyalty points and other coupons to buy formula. Breast feeding rates are lower among parents on lower incomes, meaning they are disproportionately affected.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.